关于二基酸酶-IV抑制的最新情况
Sachithanantham Annapoorani Sivaraman1,2, Varatharajan Sabareesh1
1Centre for Bio-Separation Technology (CBST), Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632 014, India.
抑制剂通过抑制二二酶-IV (DPP-IV) 来为治疗2型糖尿病提供了利普丁的有希望的替代品. 本综述探讨了有效阻止DPP-IV活性的天然和合成.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 酶抑制可以抑制酶.
- 药物发现 药物发现
背景情况:
- 2型糖尿病 (T2DM) 影响全球数以百万计的人,通常是由于因克列激素失活导致的胰岛素刺激受损.
- 双基酸酶-IV (DPP-IV) 失活了像葡萄糖类-1 (GLP-1) 这样的内激素,从而导致T2DM.
- 目前的T2DM治疗包括抑制DPP-IV的gliptins,但是一种新的治疗途径.
研究的目的:
- 审查天然和合成作为二二酶-IV (DPP-IV) 抑制剂.
- 探索基于的策略来管理2型糖尿病 (T2DM).
- 要总结DPP-IV抑制剂的分析和机制.
主要方法:
- 关于天然和合成DPP-IV抑制剂的文献综述.
- 生物化学和体外试验测定的有效性的分析.
- 分子对接研究以了解抑制机制.
主要成果:
- 各种天然和合成已经证明了DPP-IV抑制活性.
- 类药物为T2DM管理提供了现有的平素药物的替代品.
- 分子对接为和DPP-IV之间的相互作用提供了洞察力.
结论:
- 抑制剂是T2DM中DPP-IV抑制的可行替代品.
- 对天然和合成的进一步研究可能会导致新的T2DM疗法.
- 了解-DPP-IV相互作用对于药物开发至关重要.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11:36A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
